Literature DB >> 30426731

Improving the identification of patients with delirium using the 4AT assessment.

Amelia Bearn1, William Lea1, Jennie Kusznir1.   

Abstract

Delirium is a common neuropsychiatric disorder that all those working with older people will have encountered at some stage. Delirium is often poorly identified in hospital settings and therefore not optimally managed. After data collection on the acute medical unit in an acute hospital trust in the UK it was evident that patients with signs of delirium were not being formally assessed and therefore not appropriately managed in many cases. A quality improvement project introduced the 4AT delirium assessment tool to try to ensure that patients with delirium were being identified. The project team carried out several plan-do-studyact cycles to bring about our changes, which included a 4AT assessment sticker for nursing staff to complete and teaching for all healthcare staff. Through involvement of all members of the multidisciplinary team and ongoing feedback and changes we were able to increase assessment of delirium from 0% to 64%. There is ongoing work to be done to continue to improve delirium management, but by initially improving the assessment and identification of delirium we will make a difference to these patients' outcomes. ©2018 RCN Publishing Company Ltd. All rights reserved. Not to be copied, transmitted or recorded in any way, in whole or part, without prior permission of the publishers.

Entities:  

Keywords:  delirium; mental health; older people

Mesh:

Year:  2018        PMID: 30426731     DOI: 10.7748/nop.2018.e1060

Source DB:  PubMed          Journal:  Nurs Older People        ISSN: 1472-0795


  1 in total

1.  Impact of a dementia-friendly program on detection and management of patients with cognitive impairment and delirium in acute-care hospital units: a controlled clinical trial design.

Authors:  N M Weldingh; M R Mellingsæter; B W Hegna; J Saltyte Benth; G Einvik; V Juliebø; B Thommessen; M Kirkevold
Journal:  BMC Geriatr       Date:  2022-03-31       Impact factor: 3.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.